Portfolio Lab

Cognex Corp

  • Stock
  • Ticker CGNX
  • ISIN US1924221039
  • Nasdaq

Technology · Electronics and instruments · USA

$44.36 −6.92%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Cognex Corp since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

CGNXGlobal equities (VT)

$10,000 grew to $16,166. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −74.6% in 04/2025, measured from the peak in 02/2021. The old peak has not been reached again yet.

1-year return
+28.0%
5-year return p.a.
−10.5%
10-year return p.a.
+4.9%
Volatility p.a.
40.2%
Largest decline
−74.6%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202504/202607/202610/2026
Income statement
Revenue230216249277252268291313
Gross profit158144168187166191206222
Operating income31264358356086101
EBITDA36314963406590105
Net income2824411833527385
Earnings per share0.170.140.240.100.200.310.430.50
Balance sheet
Total assets1,9931,9332,0042,0032,0172,0062,1792,276
Liabilities475487497513525527549555
Equity1,5181,4461,5061,4901,4921,4791,6301,721
Cash186144179246263237303695
Cash flow
Operating cash flow51414387754569106
Capital expenditure-2.1-2.5-2.2-1.5-2.6-2.8-1.5-2.6
Free cash flow49384086724268104

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2017 at +92.9%, weakest 2022 at −39.1%. 4 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026$0.50
6 Aug 2026$0.43
7 May 2026$0.31
12 Feb 2026$0.20
30 Oct 2025$0.10
31 Jul 2025$0.24
1 May 2025$0.14
13 Feb 2025$0.17
31 Oct 2024$0.17
1 Aug 2024$0.21
2 May 2024$0.07
15 Feb 2024$0.06

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€6.8bn
Market cap in trading currency
$7.47bn
Enterprise value
$6.77bn
P/E
30.8
P/S
6.64
P/B
4.34
EV/Sales
6.02
EV/EBITDA
22.6
Earnings yield
3.2%
FCF yield
3.8%

Results (last four quarters)

Revenue
$1.13bn
Gross profit
$784m
EBITDA
$300m
Net income
$242m
Earnings per share
$1.44
Revenue per share
$6.68
Revenue growth
+13.2%
Earnings growth
+380.2%

Profitability

Gross margin
69.7%
Operating margin
25.0%
Net margin
21.5%
Return on equity
15.1%
Return on assets
10.6%

Balance sheet and cash flow

Cash
$696m
Cash per share
$4.13
Financial debt
–
Debt/equity %
–
Current ratio
5.04
Book value per share
$10.22
Operating cash flow
$296m
Free cash flow
$286m

Dividend

Dividend yield
0.57%
Dividend (12 months)
$0.26
Yield (12 months)
0.57%
Payout ratio
18%
Ex-dividend date
20 Aug 2026

Shares and trading

Shares outstanding
168m
Volume
5.41m
Avg. volume 3 months
1.85m
Relative volume
3.0

Price and technicals

Price
$44.36
1 day
−6.9%
52-week high
$72.42
52-week low
$34.80
Distance to 52-week high
−38.7%
Distance to 52-week low
+27.5%
Distance to 50-day line
−21.6%
Distance to 200-day line
−24.4%
RSI (14)
31
Volatility 1M
67.0%

Performance

1 week
−11.3%
1 month
−18.8%
3 months
−24.2%
6 months
−32.9%
YTD
+23.3%
1 year
+22.9%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
4 Oct 2026

Frequently asked questions

How has CGNX performed since 11/2016?

$10,000 grew to $16,166 by 20 Nov 2026, which is +4.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is CGNX?

Volatility was 40.2% per year, measured on monthly returns. The largest decline from a peak was −74.6%, with the low in 04/2025.

How does CGNX compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, CGNX returned +4.9% at 40.2%. The correlation of monthly returns was 0.63; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Cognex Corp (CGNX): Return and risk | Portfolio Lab